Rheumatoid Arthritis Newsletter sign up now
-
MRC Scientists Announce Advance In Understanding Body's Natural Defences
... and other disease such as Lupus and rheumatoid . Dr Melania Capasso, one of the ... autoimmune diseases such as Lupus (and rheumatoid arthritis. Source: Leicester University (Hover over the stars ...
-
Cally scare as blood test shows up cancer
... between 1986 and 1989 and on loan in 2000, had been taking tablets for rheumatoid arthritis which had caused him pain for five years. The medicine meant he had to ...
-
Research sheds light on the inner workings of the inflammatory response to Leishmaniasis
... these granulomas, in spite of their occurrence in other human diseases, from tuberculosis to rheumatoid arthritis. The York-based research team used an advanced laser-based microscopy technique, called '2-photon imaging', to ...
-
Advance in Understanding Body's Natural Defenses
... of B cell lymphoma and the treatment of autoimmune diseases such as Lupus (and rheumatoid arthritis). ...
-
Abbott Seeks FDA Approval For Lupron Depot 45-mg Six Month Formulation
... Roche and Biogen Idec have decided to suspend Ocrelizumab treatment of patients in the rheumatoid arthritis (RA) programme. The decision follows the recommendation of the ... Elanco, the animal health ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Nektar Announces Positive Phase 2 Clinical Data from First Stage of NKTR-102 Study in Women with Platinum-Resistant Ovarian Cancer
... or Europe for leading biopharmaceutical company partners, including UCB's Cimzia(R) for Crohn's disease and rheumatoid arthritis, Roche's PEGASYS(R) for hepatitis C and Amgen's Neulasta(R) for neutropenia. Nektar has created a ...
-
Swedish Orphan Biovitrum has agreed to an additional Kineret(R) drug campaign with Amgen
... 2008, Swedish Orphan Biovitrum obtained from Amgen the global exclusive rights to Kineret® for rheumatoid arthritis as currently indicated on its label. In November 2009, the agreement regarding Swedish Orphan ...
-
Swedish Orphan Biovitrum has agreed to an additional Kineret(R) drug campaign with Amgen (MRW)
... December 2008, Swedish Orphan Biovitrum obtained from the global exclusive rights to Kineret for rheumatoid arthritis as currently indicated on its label. In November 2009, the agreement regarding Swedish Orphan ...
-
Sanofi-aventis Acquires Chattem
... Roche and Biogen Idec have decided to suspend Ocrelizumab treatment of patients in the rheumatoid arthritis (RA) programme. The decision follows the recommendation of the ... AstraZeneca has reported top-line ...
-
CBio secures clinical trial milestone under option agreement with Novo Nordisk
... therapy which could provide safer and more effective treatment of autoimmune diseases such as rheumatoid arthritis. The clinical trial milestone was triggered by the recruitment of the 75th patient into ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
-
Aethlon Medical to Present at The Salk Institute (PRN)
... for research purposes and potential reintroduction into patients afflicted with autoimmune conditions such as Rheumatoid Arthritis and Lupus. and Exosome Sciences can be accessed online at Certain of the ...
-
Aethlon Medical to Present at The Salk Institute
... for research purposes and potential reintroduction into patients afflicted with autoimmune conditions such as Rheumatoid Arthritis and Lupus. Additional information regarding Aethlon Medical and Exosome Sciences can be accessed ...
-
Medication Fears Lead to Worse Side Effects
... and her colleagues note in the journal Arthritis Care & Research, they can still be ... well, Nestoriuc and her team had 100 rheumatoid arthritis patients complete the Beliefs about Medicines ...
-
Facet Biotech Wooed by $722M Acquisition Offer from Abbott
... served as executive vice president of Biogen's Oncology/Rheumatology Strategic Business Unit. But despite what appeared ... far is Humira (adalimumab), an antibody for rheumatoid arthritis, psoriasis, Crohn's disease and ankylosing spondylitis. It ...
-
MRC scientists announce advance in understanding body's natural defenses
... defenses Research program at the University of Leicester has potential for therapies for lupus, rheumatoid arthritis and types of cancer Medical Research Council (MRC) scientists at the University of Leicester ...
- Don’t see the news you want? Customize your own newsletters. Sign up for a FREE TRIAL to the Inbox Robot Today. Click Here.
Presswire
Press Release Distribution Service
News publications
- World News Report
- US Politics Today
- EU Politics Today
- Healthcare Industry Today
- Music Industry Today
- Agriculture Industry Today
- Energy Industry Today
- IT Industry Today
- Airline Industry Today
- Automotive Industry Today
- Finance Industry Today
© 2005-2010